Transient Ara-C leukoencephalopathy: MR findings

Journal of Computer Assisted Tomography

Volumn 20, Issue 1, 1996, Pages 161-162

  Patel, Anil G ^a   Rao, Ramani ^a  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOENCEPHALOPATHY;

CYTARABINE; IDARUBICIN;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG EFFECT; HUMAN; LEUKOENCEPHALOPATHY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030026995     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199601000-00030     Document Type: Article

References (14)

1. Herzig RH, Wolff SN, Lazeisus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemias. Blood 1983;62:361-9.
2. Early AP, Preisler HD, Highly DJ, et al. High-dose cytosine arabinoside: clinical response to therapy in acute leukemia. Med Pediatr Oncol 1982;10(suppl):239-50.
3. Winkelman MD, Hines JD. Cerebellum degeneration caused by high dose cytosine arabinoside: A clinicopathological study. Ann Neurol 1983;14:520-7.
4. Balis FM, Poplcnek DG. Central nervous system pharmacology of antileukemia drugs. Ann J Pediatr Hematol Oncol 1989;11:74-86.
5. Dworkin LA, Goldman RD, Zivin LS, Fuchs PC. Cerebellar toxicity following high dose cytosine arabinoside. J Clin Oncol 1985;3:613-16.
6. Salinsky ME, Levine RL, Abcbuchon JP, Schutter HS. Acute cerebellar dysfunction with high dose Ara-C therapy. Cancer 1983;51:426-9.
7. Lazeirus HM, Herzig RM, et al. Central nervous system toxicity of high dose system cytosine arabinoside. Cancer 1981;48:2577-82.
8. Berger A, Browman GP, Walker IR. Clinical evidence of a cumulative effect of high-dose cytosine arabinoside on the cerebellum in patients with acute leukemia: A leukemia intergroup report. Cancer Treat Rep 1985;69:240-1.
9. Herziz RH, Lazarus HM, Wolff SN, Phillips GL, Herziz GP. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia. J Clin Oncol 1985;3:992-7.
10. Barnett MJ, Richods MA, Ganescion TS, et al. Central nervous system toxicity of high-dose cytosine. Semin Oncol 1985;12(suppl 3):227-32.
11. Herziz RH, Lazerous HM, Herziz GR, Coceita PF, Wolff SN. Central nervous system toxicity with high-dose cytosine arabinoside. Semin Oncol 1985;12(suppl 3):233-6.
12. Hwang T, Yng WKA, Estey EH, Fields WS. Central nervous system toxicity with high-dose Ara-C. Neurology 1985;35:1475-9.
13. Winklemein MD, Hines JD. Cerebellum degeneration caused by high-dose cytosine arabinoside: A clinicopathological study. Ann Neurol 1983;14:520-8.
14. Millar L, Link M, Bologna S, Parker B. Cerebellum atrophy caused by high-dose cytosine arabinoside: CT & MR findings. AJR 1989;152:343-4.